Clinical Trial Update: Role of Perhexiline in Hypertrophic Cardiomyopathy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring perhexiline for hypertrophic cardiomyopathy is ongoing or not yet updated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertrophic Cardiomyopathy

Drugs mentioned

• Perhexiline (perhexiline)

Snippet

Sponsor: Flinders University | Conditions: Hypertrophic Cardiomyopathy | Phase 2 | Status: UNKNOWN